{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:41:24Z","timestamp":1769110884341,"version":"3.49.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":1413,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T00:00:00Z","timestamp":1642809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study aimed to develop and validate a competing risk nomogram for predicting all-cause mortality and heart transplantation (HT) before first appropriate shock in non-ischaemic dilated cardiomyopathy (DCM) patients receiving implantable cardioverter-defibrillators (ICD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A total of 218 consecutive DCM patients implanted with ICD between 2010 and 2019 at our institution were retrospectively enrolled. Cox proportional hazards model was primarily built to identify variables associated with death and HT. Then, a Fine\u2013Gray model, accounting for the appropriate shock as a competing risk, was constructed using these selected variables along with implantation indication (primary vs. secondary). Finally, a nomogram based on the Fine\u2013Gray model was established to predict 1-, 3-, and 5-year probabilities of all-cause mortality and HT before first appropriate shock. The area under the receiver operating characteristic (ROC) curve (AUC), Harrell's C-index, and calibration curves were used to evaluate and internally validate the performance of this model. The decision curve analysis was applied to assess its clinical utility. The 1-, 3-, and 5-year cumulative incidence of all-cause mortality and HT without former appropriate shock were 5.3% [95% confidence interval (CI) 2.9\u20139.9%], 16.6% (95% CI 11\u201325.0%), and 25.3% (95% CI 17.2\u201337.1%), respectively. Five variables including implantation indication, left ventricular end-diastolic diameter, N-terminal pro-brain natriuretic peptide, angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker, and amiodarone treatment were independently associated with it (all P &amp;lt; 0.05) and were used for constructing the nomogram. The 1-, 3-, and 5-year AUC of the nomogram were 0.83 (95% CI 0.73\u20130.94, P &amp;lt; 0.001), 0.84 (95% CI 0.75\u20130.93, P &amp;lt; 0.001), and 0.85 (95% CI 0.77\u20130.94, P &amp;lt; 0.001), respectively. The Harrell's C-index was 0.788 (95% CI 0.697\u20130.877, P &amp;lt; 0.001; 0.762 for the optimism-corrected C-index), showing the good discriminative ability of the model. The calibration was acceptable (optimism-corrected slope 0.896). Decision curve analysis identified our model was clinically useful within the entire range of potential treatment thresholds for ICD implantation. Three risk groups stratified by scores were significantly different between cumulative incidence curves (P &amp;lt; 0.001). The identified high-risk group composed 17.9% of our population and did not derive long-term benefit from ICD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The proposed nomogram is a simple, useful risk stratification tool for selecting potential ICD recipients in DCM patients. It might facilitate the shared decision-making between patients and clinicians.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.13808","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T04:33:49Z","timestamp":1642826029000},"page":"1269-1278","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Nomogram Predicting Death and Heart Transplantation Before Appropriate ICD Shock in Dilated Cardiomyopathy"],"prefix":"10.1093","volume":"9","author":[{"given":"Yu","family":"Deng","sequence":"first","affiliation":[{"name":"Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , No. 167 Bei Li Shi Road, Xicheng District, Beijing, 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nixiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , No. 167 Bei Li Shi Road, Xicheng District, Beijing, 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Hua","sequence":"additional","affiliation":[{"name":"Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , No. 167 Bei Li Shi Road, Xicheng District, Beijing, 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijing","family":"Cheng","sequence":"additional","affiliation":[{"name":"Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , No. 167 Bei Li Shi Road, Xicheng District, Beijing, 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxia","family":"Niu","sequence":"additional","affiliation":[{"name":"Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , No. 167 Bei Li Shi Road, Xicheng District, Beijing, 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuhua","family":"Chen","sequence":"additional","affiliation":[{"name":"Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , No. 167 Bei Li Shi Road, Xicheng District, Beijing, 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Gu","sequence":"additional","affiliation":[{"name":"Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , No. 167 Bei Li Shi Road, Xicheng District, Beijing, 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi","family":"Cai","sequence":"additional","affiliation":[{"name":"Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , No. 167 Bei Li Shi Road, Xicheng District, Beijing, 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Liu","sequence":"additional","affiliation":[{"name":"Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , No. 167 Bei Li Shi Road, Xicheng District, Beijing, 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Huang","sequence":"additional","affiliation":[{"name":"Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , No. 167 Bei Li Shi Road, Xicheng District, Beijing, 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minsi","family":"Cai","sequence":"additional","affiliation":[{"name":"Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , No. 167 Bei Li Shi Road, Xicheng District, Beijing, 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , No. 167 Bei Li Shi Road, Xicheng District, Beijing, 100037 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,1,22]]},"reference":[{"key":"2026012114163948800_ehf213808-bib-0001","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012114163948800_ehf213808-bib-0002","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"key":"2026012114163948800_ehf213808-bib-0003","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0735-1097(03)00297-3","article-title":"Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia\u2014AMIOVIRT","volume":"41","author":"Strickberger","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026012114163948800_ehf213808-bib-0004","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","article-title":"Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated Cardiomyopathy","volume":"105","author":"Ba\u0308nsch","year":"2002","journal-title":"Circulation"},{"key":"2026012114163948800_ehf213808-bib-0005","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"key":"2026012114163948800_ehf213808-bib-0006","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1093\/eurheartj\/ehaa226","article-title":"Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study","volume":"41","author":"Zabel","year":"2020","journal-title":"Eur Heart J"},{"key":"2026012114163948800_ehf213808-bib-0007","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"2026012114163948800_ehf213808-bib-0008","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026012114163948800_ehf213808-bib-0009","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.006155","article-title":"Risk of appropriate therapy and death before therapy after implantable cardioverter-defibrillator generator replacement","volume":"11","author":"Witt","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026012114163948800_ehf213808-bib-0010","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/eurheartj\/ehs177","article-title":"Long-term benefit of implantable cardioverter\/defibrillator therapy after elective device replacement: results of the INcidence free SUrvival after ICD REplacement (INSURE) trial\u2014a prospective multicentre study","volume":"34","author":"Erkapic","year":"2013","journal-title":"Eur Heart J"},{"key":"2026012114163948800_ehf213808-bib-0011","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/europace\/euz121","article-title":"Incidence of appropriate implantable cardioverter-defibrillator therapy and mortality after implantable cardioverter-defibrillator generator replacement: results from a real-world nationwide cohort","volume":"21","author":"Ruwald","year":"2019","journal-title":"Europace"},{"key":"2026012114163948800_ehf213808-bib-0012","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/europace\/euq494","article-title":"Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients","volume":"13","author":"van Welsenes","year":"2011","journal-title":"EP Europace"},{"key":"2026012114163948800_ehf213808-bib-0013","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/europace\/eut302","article-title":"Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population","volume":"16","author":"Buber","year":"2014","journal-title":"Europace"},{"key":"2026012114163948800_ehf213808-bib-0014","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.hrthm.2016.11.025","article-title":"Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication","volume":"14","author":"Boersma","year":"2017","journal-title":"Heart Rhythm"},{"key":"2026012114163948800_ehf213808-bib-0015","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/eurheartj\/eht511","article-title":"Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark","volume":"35","author":"Kirkfeldt","year":"2014","journal-title":"Eur Heart J"},{"key":"2026012114163948800_ehf213808-bib-0016","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jacep.2019.11.005","article-title":"Impact on all-cause and cardiovascular mortality of cardiac implantable electronic device complications","volume":"6","author":"Palmisano","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"2026012114163948800_ehf213808-bib-0017","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.116.027134","article-title":"Personalizing risk stratification for sudden death in dilated cardiomyopathy: the past, present, and future","volume":"136","author":"Halliday","year":"2017","journal-title":"Circulation"},{"key":"2026012114163948800_ehf213808-bib-0018","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/CIRCHEARTFAILURE.115.002414","article-title":"Clinical risk stratification for primary prevention implantable cardioverter defibrillators","volume":"8","author":"Lee","year":"2015","journal-title":"Circ Heart Fail"},{"key":"2026012114163948800_ehf213808-bib-0019","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijcard.2018.06.103","article-title":"Differential multivariable risk prediction of appropriate shock versus competing mortality\u2014a prospective cohort study to estimate benefits from ICD therapy","volume":"272","author":"Bergau","year":"2018","journal-title":"Int J Cardiol"},{"key":"2026012114163948800_ehf213808-bib-0020","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.jacc.2017.03.568","article-title":"Seattle heart failure and proportional risk models predict benefit from implantable cardioverter-defibrillators","volume":"69","author":"Bilchick","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026012114163948800_ehf213808-bib-0021","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N Engl J Med"},{"key":"2026012114163948800_ehf213808-bib-0022","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","article-title":"Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT)","volume":"105","author":"B\u00e4nsch","year":"2002","journal-title":"Circulation"},{"key":"2026012114163948800_ehf213808-bib-0023","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.hrthm.2015.04.040","article-title":"Thirteen-year nationwide trends in use of implantable cardioverter-defibrillators and subsequent long-term survival","volume":"12","author":"Schmidt","year":"2015","journal-title":"Heart Rhythm"},{"key":"2026012114163948800_ehf213808-bib-0024","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jacep.2016.06.001","article-title":"Survival after secondary prevention implantable cardioverter-defibrillator placement: an analysis from the NCDR ICD registry","volume":"3","author":"Katz","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"2026012114163948800_ehf213808-bib-0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/europace\/euv188","article-title":"Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication","volume":"18","author":"Schaer","year":"2016","journal-title":"Europace"},{"key":"2026012114163948800_ehf213808-bib-0026","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017002","article-title":"Baseline and dynamic risk predictors of appropriate implantable cardioverter defibrillator therapy","volume":"9","author":"Wu","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2026012114163948800_ehf213808-bib-0027","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.amjcard.2018.02.055","article-title":"Arrhythmic risk stratification in patients with idiopathic dilated cardiomyopathy","volume":"121","author":"Stolfo","year":"2018","journal-title":"Am J Cardiol"},{"key":"2026012114163948800_ehf213808-bib-0028","first-page":"1121","article-title":"A novel risk stratification score for sudden cardiac death prediction in middle-aged, nonischemic dilated cardiomyopathy patients: the ESTIMATED score","volume":"36","author":"Li","year":"2020","journal-title":"Can J Cardiol"},{"key":"2026012114163948800_ehf213808-bib-0029","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacep.2016.09.006","article-title":"Does the implantable cardioverter-defibrillator benefit vary with the estimated proportional risk of sudden death in heart failure patients?","volume":"3","author":"Levy","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"2026012114163948800_ehf213808-bib-0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jchf.2014.04.006","article-title":"Factors influencing the predictive power of models for predicting mortality and\/or heart failure hospitalization in patients with heart failure","volume":"2","author":"Ouwerkerk","year":"2014","journal-title":"JACC Heart Fail"},{"key":"2026012114163948800_ehf213808-bib-0031","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","article-title":"The Seattle Heart Failure Model: prediction of survival in heart failure","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"key":"2026012114163948800_ehf213808-bib-0032","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/europace\/euaa193","article-title":"Prognostic impact of multiple fragmented QRS on cardiac events in idiopathic dilated cardiomyopathy","volume":"23","author":"Marume","year":"2021","journal-title":"Europace"},{"key":"2026012114163948800_ehf213808-bib-0033","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1161\/CIRCULATIONAHA.108.816884","article-title":"Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population","volume":"120","author":"Levy","year":"2009","journal-title":"Circulation"},{"key":"2026012114163948800_ehf213808-bib-0034","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jchf.2019.03.019","article-title":"Risk models for prediction of implantable cardioverter-defibrillator benefit: insights from the DANISH trial","volume":"7","author":"Kristensen","year":"2019","journal-title":"JACC Heart Fail"},{"key":"2026012114163948800_ehf213808-bib-0035","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/CIRCULATIONAHA.107.742155","article-title":"Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study","volume":"117","author":"Koller","year":"2008","journal-title":"Circulation"},{"key":"2026012114163948800_ehf213808-bib-0036","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"2026012114163948800_ehf213808-bib-0037","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006220","article-title":"Mortality implications of appropriate implantable cardioverter defibrillator therapy in secondary prevention patients: contrasting mortality in primary prevention patients from a prospective population-based registry","volume":"6","author":"Almehmadi","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2026012114163948800_ehf213808-bib-0038","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.hrthm.2015.06.039","article-title":"A novel method to predict the proportional risk of sudden cardiac death in heart failure: derivation of the Seattle Proportional Risk Model","volume":"12","author":"Shadman","year":"2015","journal-title":"Heart Rhythm"},{"key":"2026012114163948800_ehf213808-bib-0039","article-title":"Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death","volume":"2021","author":"Claro","year":"2015","journal-title":"Cochrane Database Syst Rev"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.13808","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.13808","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/2\/1269\/65375477\/eschf_9_2_1269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/2\/1269\/65375477\/eschf_9_2_1269.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:19:51Z","timestamp":1769023191000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/9\/2\/1269\/8326192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,22]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,1,22]]},"published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.13808","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4]]},"published":{"date-parts":[[2022,1,22]]},"assertion":[{"value":"2021-08-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}